These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31361509)

  • 1. Population-Based Epidemiology of Pediatric Patients with Treated Tic Disorders from Real-World Evidence in Korea.
    Choi S; Lee H; Song DH; Cheon KA
    J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):764-772. PubMed ID: 31361509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation on the status of monotherapy for newly diagnosed tic disorders and its comorbidity in children].
    Lu Q; Cui YH; Liu ZS; Sun D; Fang F; Peng J; Zhou SZ; Wang JQ; Luo R; Jiang L; Qin J; Jiang YW; Zheng Y
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):887-892. PubMed ID: 33120459
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.
    Song I; Shin JY
    Epidemiol Health; 2016; 38():e2016045. PubMed ID: 27866408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
    Demirkaya SK; Demirkaya M; Yusufoğlu C; Akın E
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):104-105. PubMed ID: 27315236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea.
    Cho Y; Kim AY; Lee S; Lee H
    Int Clin Psychopharmacol; 2024 Jul; 39(4):240-249. PubMed ID: 38477521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert consensus on pharmacotherapy for tic disorders in Japan.
    Hamamoto Y; Fujio M; Nonaka M; Matsuda N; Kono T; Kano Y
    Brain Dev; 2019 Jun; 41(6):501-506. PubMed ID: 30795919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Treatment of Comorbid Attention-Deficit/Hyperactivity Disorder and Tourette and Tic Disorders.
    Jaffe RJ; Coffey BJ
    Child Adolesc Psychiatr Clin N Am; 2022 Jul; 31(3):469-477. PubMed ID: 35697396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
    Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
    Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental disorders: prevalence and comorbidity in children referred to mental health services.
    Hansen BH; Oerbeck B; Skirbekk B; Petrovski BÉ; Kristensen H
    Nord J Psychiatry; 2018 May; 72(4):285-291. PubMed ID: 29488416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
    Yu SH; Chou JY; Robson D; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1355-6. PubMed ID: 20619310
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Tic-Suppressing Medication and Other Psychotropic Drugs in Children and Adolescents with Newly Diagnosed Tic Disorders in Denmark.
    Rasmussen L; Bilenberg N; Thrane JM; Ernst MT; Pottegård A
    J Child Adolesc Psychopharmacol; 2020 Oct; 30(8):476-485. PubMed ID: 32882143
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
    Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
    Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.